Navigation Links
A Collaboration to Find New Tools to Fight Leukemia

Mayo Clinic Cancer Center, working in collaboration with Ohio State University Comprehensive Cancer Center//, presented evidence Sunday that a novel regimen of three chemotherapy drugs, pentostatin, cyclophosphamide and rituximab, resulted in significant clinical response in patients with previously untreated chronic lymphocytic leukemia (CLL). Lead researcher and Mayo Clinic hematologist Neil E. Kay, M.D., presented these findings at the 2006 American Society of Hematology Annual Meeting in Orlando.

“Chronic lymphocytic leukemia is incurable, but continues to be made more manageable with the advent of powerful new chemoimmunotherapy tools,” says Dr. Kay. “We and our collaborators at Ohio State University, in particular Dr. Michael Grever, have done previous research on pentostatin that led us to believe there would be success with this regimen, and are pleased with the results.”

Regimens using rituximab are common for CLL patients, says Dr. Kay, and his team decided to build upon that knowledge and their understanding of the highly potent chemotherapeutic antibiotic pentostatin to try to develop an even better treatment option. The investigators initiated a trial of three weeks (one cycle) of combined chemotherapy drugs pentostatin (P), cyclophosphamide (C) and rituximab (R) repeated in six cycles for 64 symptomatic but previously untreated patients. Patients in the study also received one year of prophylactic sulfamethoxazole-trimethoprim (anti-infection drug) and acyclovir (antiviral drug) along with the PCR treatment.

The researchers reviewed study participants’ prognostic status and divided the patients into risk categories at the beginning of the study, using a number of different prognostic evaluation tools to describe them, including the Rai stages (clinical levels of disease progression), CD38 and ZAP-70 (overexpressed proteins found in CLL cells), IgVH (mutational status of the immunoglobulin gene occurring in CLL patien
'"/>




Page: 1 2

Related medicine news :

1. Collaborations planned between British Organization and Indian health care industry
2. Crusade Against Cancer: Collaborations On The Anvil
3. Mayo Clinic and Indian Health Service Form Clinical Practice Collaboration
4. International Collaboration Takes Aim at Rabies
5. British Medical Association Plans Collaboration With India
6. British Medical Association Plans Collaboration With India
7. LondonMet Keen on Widening Research Collaborations With India
8. New Tools To Identify Flu Strains
9. Is There a Connection between Hearing loss and High-speed Dental Tools?
10. Software Tools & Fonts in Seven Indian Languages
11. ‘Dirty’ and Dangerous Tools Put Full Stop to Operatin
Post Your Comments:
(Date:12/5/2009)NEW ORLEANS, Dec. 5 There have been significant scientific advances in the field of blood cancers, and leading experts continue to gain a better understanding of how certain diseases progress in orde
(Date:12/5/2009)NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual Meeting of the American Society of Hematology int
(Date:12/5/2009)AVIVA today announced the launch of International Solutions, an innovative new international private medical insurance plan which follows the acclaimed modular design of its UK equivalent. In addition
(Date:12/4/2009)NEW YORK, Dec. 4 Care Investment Trust Inc. (NYSE: CRE ) ("Care" or the "Company") today announced that its Board of Directors has declared a dividend of $0.17 per share of common stock. The div
(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
Breaking Medicine News(10 mins):Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2
...sychologists have found in a study that instead of...how one feels about their body shape and thereby a...ies the way they are end up with the lowest body m...ology and one of the researchers said that eating ...
...abeling mix-up among about 135 people, whose blood...d to a re-test among 90 people as one of the patie...test in April. The pathology center has conc...hs without knowing it. The mix-up was reveal...
...o assess the economic impact of air quality change...re found to be second only to timber losses in ter...ished in the Canadian Journal of Forest Research, ...imates the effects in terms of health risk to be b...
... in mice has found that though they do not develop...ty researchers were able to differentiate the cell...or the oily skin. The research examines how a seba...t Rockefeller University, settles this argument, s...
...ity Improvement Scotland (QIS) review of the perfo... in 2003 for food, fluid and nutritional care find... The NHS Quality Improvement Scotland had iss...dmitted following concerns about the number of und...
...essive amounts of soda and sugary drinks is making...iew.// Frank Hu and his colleagues at the Har...dible scientific nutrition studies conducted over ...erages account for half of those calories, reporte...
Other Medicine News:Health News:Study Finds Healthier Women Are Those Who Accept The Way They Look 2Health News:'Blimp1' Gene Linked To Oily Skin 2
(Date:12/4/2009)SAN DIEGO, Calif., Dec. 4 Suneva Medical, a privately-held aesthetic medical device company, today announced the appointment of Philip Ranker as Vice President and Chief Financial Officer. In this r
(Date:12/4/2009)BETHESDA, Md., Dec. 4 Drs. Neal Shore and E. David Crawford presented results for prostate-specific antigen (PSA) recurrence from the additional analysis of secondary end points of biochemical recurr
(Date:12/3/2009)ACTON, Mass., Dec. 3 Allen Medical Systems, a subsidiary of Hill-Rom Holdings, Inc. (NYSE: HRC ), today announced the launch of its new Allen Amatech(TM) OEM (Original Equipment Manufacturer) busin
Breaking Medicine Technology:Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Many Hospitals Are Not Ready for H1N1 3A Nurse Survey Shows Deficiencies in Hospital Swine Flu Readiness 55369 1Many Hospitals Are Not Ready for H1N1 3A Nurse Survey Shows Deficiencies in Hospital Swine Flu Readiness 55369 2Many Hospitals Are Not Ready for H1N1 3A Nurse Survey Shows Deficiencies in Hospital Swine Flu Readiness 55369 3Top Newport Beach Plastic Surgeon Appointed President of Orange County Society of Plastic Surgeons 55366 1Top Newport Beach Plastic Surgeon Appointed President of Orange County Society of Plastic Surgeons 55366 2eMindful Offers Employers Complete Set of Wellness Tools Partnership with Online Health Coaching Service Rounds Out Health Package 55361 1eMindful Offers Employers Complete Set of Wellness Tools Partnership with Online Health Coaching Service Rounds Out Health Package 55361 2eMindful Offers Employers Complete Set of Wellness Tools Partnership with Online Health Coaching Service Rounds Out Health Package 55361 3
...sponse Network (LRN), the national laboratory syst...ergencies, will mark its first decade at its natio..., , Founded in 1999 by the Association of Public ...e Control and Prevention (CDC) and the Federal Bur...ioterrorism, the Laboratory Response Network has e...
.... (Nasdaq: ARNA ) today announced it will hold a...2009 at 8:30 a.m. Eastern Time (5:30 a.m. Pacific ...vioral modification and Lorcaserin for Overweight ...trials evaluating the safety and efficacy of lorca...and Chief Executive Officer, Dominic P. Behan, Ph....
Other Medicine Technology:Nation's Laboratory Response Network Marks First Decade of Protecting Public Health 2Arena Pharmaceuticals to Host Conference Call and Webcast on Monday, March 30, 2009 to Discuss Lorcaserin Pivotal Phase 3 Obesity Trial Results 2Arena Pharmaceuticals to Host Conference Call and Webcast on Monday, March 30, 2009 to Discuss Lorcaserin Pivotal Phase 3 Obesity Trial Results 3
5F Infiniti
Softtouch
CT Micro Stereotactic System
Tapered Tefcor Movable Core Wire Guides
Medicine Products: